Medical Doctor Program year 2019 Source: CMS Open Payments, 2026 publication

Frederik Hansen

Gastroenterology Lutherville, MD Medical Doctor

NPI 1982662177 CMS profile 271964

10751 Falls Rd, Suite 303, Lutherville, MD 21093

Open in the dashboard

General payments

$963

61 records reported · program year 2019

Research payments

$0

Paid to them · None reported · program year 2019

Ownership & investment interest

$0

None reported

Through program year 2019, Frederik Hansen of Lutherville, MD is reported in the CMS Open Payments database as having received $963 across 61 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 34th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2019 General $963 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Frederik Hansen
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Frederik Hansen were reported at $0. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Frederik Hansen Gastroenterology median Middle half National median
2019 $963 $417 $126–$1,100 $163
2020 $0 $224 $74–$624 $114
2021 $0 $352 $106–$1,054 $132
2022 $0 $448 $129–$1,270 $149
2023 $0 $533 $150–$1,390 $160
2024 $0 $605 $160–$1,606 $164
2025 $0 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program year 2019
  1. AbbVie, Inc. $468 30 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $142 10 payments
  3. QOL Medical, LLC $113 8 payments
  4. Janssen Biotech, Inc. $73 3 payments
  5. Pfizer Inc. $64 4 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $56 3 payments
  7. Daiichi Sankyo Inc. $35 2 payments
  8. Allergan Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program year 2019
  1. Food and Beverage $963 61 payments
Products named General payments · program year 2019
  1. HUMIRA $346 22 payments
  2. Sucraid $113 8 payments
  3. CREON $105 7 payments
  4. STELARA $73 3 payments
  5. Motegrity $71 4 payments
  6. Entyvio $71 6 payments
  7. XELJANZ $64 4 payments
  8. XIFAXAN $56 3 payments
  9. INJECTAFER $35 2 payments
  10. INFLECTRA $34 2 payments
  11. Other $23 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

61 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2019

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record